Chemicals
Ended Awarded Last action
- Contract number
- HHSN26300026
- Awardee
-
New England Biolabs, Inc. UEI EDKJNT8DADG8
- Awarding agency
-
Office of the Director
National Institutes of Health, Department of Health and Human Services
- Obligated
- $5,144
Award facts
- Contract value 50% obligated
-
- $5,143.50 Current, with exercised options
- $10,287.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Ipswich, MA 01938, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $5,144 |
About this award
This federal contract award was made to New England Biolabs, Inc., a leading manufacturer and supplier of molecular biology products, by the National Institutes of Health (NIH). The $10,287 firm fixed price contract is a Blanket Purchase Agreement (BPA) call order that will run through December 31, 2012. The contract is for the provision of chemicals, drugs, and biologicals, with no set-aside designation.
New England Biolabs specializes in reagents, kits, and enzymes for life sciences research, particularly in areas such as genomics, infectious disease research, and molecular biology. The company has consistently provided a wide range of specialized products to multiple federal agencies through contract awards, including the National Institute of Allergy and Infectious Diseases (NIAID), National Human Genome Research Institute (NHGRI), and Centers for Disease Control and Prevention (CDC). This contract is part of a larger $10,000,000 BPA with the NIH Office of Logistics and Acquisition Operations, which enables various NIH components to efficiently procure essential molecular biology products for their research activities.
Quick answers
Who was awarded contract HHSN26300026?
HHSN26300026 was awarded to New England Biolabs, Inc. by Office of the Director (National Institutes of Health) on March 20, 2012.
How much is contract HHSN26300026 worth?
The government has obligated $5,144 on HHSN26300026. Its potential value, with all options, is $10,287.
Is contract HHSN26300026 an order under another contract?
Yes. HHSN26300026 is a BPA call under HHSN263201100018B, a blanket purchase agreement.
Was contract HHSN26300026 competed?
The extent of competition for HHSN26300026 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award